ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Advanced Search

Nuclear Factor of Activated T-Cells Post-Renal Transplant.

K. Tornatore,1,4 K. Attwood,2 O. McGuire,3 K. O'Loughlin,3 R. Venuto,4 H. Minderman.3

1Translational Pharmacology Research Center, School of Pharmacy, Buffalo
2Biostatistics, School of Public Health, Buffalo
3Flow Cytometry Laboratory, Roswell Park Cancer Institute, Buffalo
4Medicine, School of Medicine, University at Buffalo, Buffalo.

Meeting: 2016 American Transplant Congress

Abstract number: D235

Keywords: FK506, Kidney transplantation, Pharmacokinetics, T helper cells

Session Information

Date: Tuesday, June 14, 2016

Session Name: Poster Session D: Poster Session II: Kidney Complications-Other

Session Time: 6:00pm-7:00pm

 Presentation Time: 6:00pm-7:00pm

Location: Halls C&D

Related Abstracts
  • Tacrolimus (Tac), Rather Than Cyclosporine (CsA), Interacts with Insulin Resistance (IR) to Alter Key Transcription Factors for β-Cell Identity & Function without Altering NFAT Localization.
  • Tacrolimus Is More Than Just a Calcineurin Inhibitor: It Suppresses NF-κB Activation in Human T Cells

Background: Nuclear Factor of Activated T-cells (NFAT1) is a transcription factor regulating the expression of key targets involved with cellular immune function. Calcineurin is a phosphatase that regulates the nuclear translocation necessary for NFAT activation and targeted by calcineurin inhibitors such as tacrolimus (TAC) for immunosuppression in renal transplant recipients (RTR). TAC doses are individualized using therapeutic drug monitoring (TDM) of extracellular troughs due to PK variability. We assessed nuclear NFAT1 localization as a pharmacodynamic (PD) marker with TAC PK.

Methods:We enrolled 47 (25 males; 22 females) stable RTR > 6 months post-transplant receiving TAC and mycophenolic acid. NFAT activation was measured at TAC trough (0 hour) and 4 hour after drug (post-peak) in CD4 and CD8 lymphocytes. Baseline nuclear localization of NFAT (unstimulated) and localization following ex-vivo exposure to PMA/Ionomycin (stimulated) generating an Rd value was assessed by flow cytometry based image analysis. Concurrent steady-state 12-hour PK studies determined lean body weight (LBW) adjusted TAC clearance(CL) and dose-adjusted area under the concentration time curve 0-12hrs(AUC0-12).

Results: Female RTR had higher nuclear NFAT translocation in CD4 and CD8 cells when adjusted for race(*) with more rapid TAC CL and higher doses. No association of NFAT Rd translocation to TAC troughs or CL were found with a trend noted with AUC0-12/Dose (P=0.08).

Mean(SD) Males Females P Values
eGFR[ml/min/1.73m2] 56.4(17.9) 46.3(13.2) 0.034
TAC Dose[mg] 2.8(1.3) 3.4(1.9) NS
TAC Dose[mg/weight] 0.03(0.02) 0.04(0.02) 0.023
TAC Trough[ng/ml] 6.74(1.47) 6.74(1.47) NS
Tac CL/LBW  0.36(0.18) 0.58(0.32) 0.003
NFAT Rd CD4+[0hr] 0.46(0.55) 0.72(0.57) 0.088*
NFAT Rd CD4+[4hr] 0.36(0.58) 0.73(0.64) 0.041*
NFAT Rd CD8+[0hr] 0.79(0.65) 1.04(0.61) 0.182*
NFAT Rd CD8+[4hr] 0.69(0.59) 1.04(0.67) 0.052

Conclusion: These data suggest a gender difference in NFAT nuclear translocation in CD4 and CD8 cells and may be reflective of intracellular tacrolimus concentrations. Extracellular tacrolimus troughs alone may not adequately guide TDM of TAC immunosuppression.

CITATION INFORMATION: Tornatore K, Attwood K, McGuire O, O'Loughlin K, Venuto R, Minderman H. Nuclear Factor of Activated T-Cells Post-Renal Transplant. Am J Transplant. 2016;16 (suppl 3).

  • Tweet
  • Email
  • Print

To cite this abstract in AMA style:

Tornatore K, Attwood K, McGuire O, O'Loughlin K, Venuto R, Minderman H. Nuclear Factor of Activated T-Cells Post-Renal Transplant. [abstract]. Am J Transplant. 2016; 16 (suppl 3). https://atcmeetingabstracts.com/abstract/nuclear-factor-of-activated-t-cells-post-renal-transplant/. Accessed January 25, 2021.

« Back to 2016 American Transplant Congress

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Subtherapeutic Low Tacrolimus Trough Levels (≤3.5 Ng /ml) Are A Risk Factor For Acute Rejection And Creatinine Doubling.
  • Penis Transplantation: First U.S. Experience.
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Live Related Kidney Transplant Experience in Abuja, Nigeria – First Eight Cases Ever.
  • Penis Transplantation: First U.S. Experience.
  • Is There a Difference Between DCD and DBD Kidney Transplantation with Similar KDPI?
  • Low GFR after Kidney Donation Is Not Chronic Kidney Disease
  • Evidence of a Clinically Significant Drug-Drug Interaction between Cannabidiol and Tacrolimus: A Case Report
  • Kidney Dialysis after Heart Transplantation: The Short and Long Term Outcomes

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2021 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.